CliffBio
small molecule

TIROSINT-SOL

LEVOTHYROXINE SODIUM

Loss of exclusivitySeptember 2044latest FDA-listed patent expiry
CompanyIBSA Institut Biochimique →See this company's full patent-cliff portfolio

Drug detail

Brand nameTIROSINT-SOL
Active ingredientLEVOTHYROXINE SODIUM
Strength112MCG/ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2016
Marketing statusRX

Listed patents

PatentExpiresType
12564565September 2044product
11241382September 2039use U-3757
11096913February 2037product
10537538February 2037product

More from IBSA Institut Biochimique

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

TIROSINT-SOL patent cliff — loss of exclusivity September 2044 | CliffBio